Treating Osteoporosis with Strontium Ranelate

2010-10-29
Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Treating Osteoporosis with Strontium Ranelate

Published Date

2010-10-29

Publisher

Type

Other

Abstract

Osteoporosis can lead to significant morbidity and mortality due to fractures. Post-menopausal women with osteoporosis should follow general guidelines in regards to calcium, vitamin D, and exercise. When added to this regimen, strontium ranelate 2 grams taken daily can significantly reduce the risk of vertebral fractures as well as non-vertebral fractures. It also increased bone mineral density at the lumbar spine, femoral neck and total hip.

Description

The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

McAvoy, Sarah. (2010). Treating Osteoporosis with Strontium Ranelate. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/95882.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.